Caricamento...
Estimating 5-year risk of CIN3+ to guide the management of women aged 21–24
OBJECTIVE: Current US national guidelines recommend beginning screening at age 21 using Pap tests only, with cotesting starting at age 30. To inform the management of Pap test abnormalities among women aged 21–24, who have extremely low cancer risks, we compared risks of CIN3+ for women aged 21–24 v...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3616448/ https://ncbi.nlm.nih.gov/pubmed/23519307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/LGT.0b013e3182854399 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|